CLOVIS ONCOLOGY INC - NOTE 2.500% 9/1

CUSIP: 189464AB6

Q1 2020 13F Holders as of 31 Mar 2020

Type / Class
Debt / NOTE 2.500% 9/1
Market price (% of par)
89.09%
Total 13F principal
$93,872,002
Principal change
+$1,001,000
Total reported market value
$83,726,060
Number of holders
13
Value change
+$902,826
Number of buys
3
Number of sells
2

Quarterly Holders Quick Answers

What is CUSIP 189464AB6?
CUSIP 189464AB6 identifies 189464AB6 - CLOVIS ONCOLOGY INC - NOTE 2.500% 9/1 in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of CLOVIS ONCOLOGY INC - NOTE 2.500% 9/1 as of Q1 2020

As of 31 Mar 2020, CLOVIS ONCOLOGY INC - NOTE 2.500% 9/1 was held by 13 institutional bondholders reporting positions in Form 13F filings. These institutions reported holding $93,872,002 in principal (par value) of the bond. The largest 10 bondholders included DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C), Allianz Asset Management GmbH, FMR LLC, PALISADE CAPITAL MANAGEMENT LLC/NJ, United Asset Strategies, Inc., HIGHBRIDGE CAPITAL MANAGEMENT LLC, UBS OCONNOR LLC, BANK OF AMERICA CORP /DE/, Federation des caisses Desjardins du Quebec, and MACKAY SHIELDS LLC. This page lists 13 institutional bondholders reporting positions for the Q1 2020 filing period.
Investor Option Weight % Change % Value $ * Price (% of par) Principal Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.